Internal Medicine Alert – June 30, 2017
June 30, 2017
View Issues
-
No Single Solution to Prevent Medication Nonadherence
Simple, low-cost reminder pill bottles did not lead to more improvement in medication adherence in patients with documented poor adherence.
-
Very Low-carbohydrate Ketogenic Diet May Reverse Type 2 Diabetes
A very low-carbohydrate ketogenic diet demonstrated superiority to the plate method diet recommended by the American Diabetes Association for controlling and even reversing type 2 diabetes.
-
Treatment of Chronic Fatigue/Myalgic Encephalitis Syndrome
Blockade of IL-1 activity with anakinra failed to reduce fatigue in patients with chronic fatigue syndrome.
-
Guillain-Barré Syndrome and Hepatitis E
Hepatitis E is the most common form of viral hepatitis worldwide and often is asymptomatic, but it is commonly associated with Guillain-Barré syndrome and Guillain-Barré variants.
-
Edaravone Injection (Radicava)
The FDA has approved edaravone, the first new treatment for amyotrophic lateral sclerosis since the approval of riluzole more than 20 years ago.
-
Clinical Briefs
In this section: Effects of weight gain on the cardiovascular system; comparing sleep apnea treatments; and rhabdomyolysis brought on by exercise.